Stem Point Capital LP Edgewise Therapeutics, Inc. Transaction History
Stem Point Capital LP
- $401 Billion
- Q4 2024
A detailed history of Stem Point Capital LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 132,706 shares of EWTX stock, worth $3.16 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
132,706
Previous 19,900
566.86%
Holding current value
$3.16 Million
Previous $531 Million
567.11%
% of portfolio
0.88%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$358 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$212 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$147 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$143 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$119 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.5B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...